Renee Lentini - 12 Sep 2023 Form 4 Insider Report for ImmunoGen, Inc.

Role
PRIN. FIN & ACCTG. OFF.
Signature
/s/ Renee Lentini
Issuer symbol
N/A
Transactions as of
12 Sep 2023
Net transactions value
+$99,808
Form type
4
Filing time
14 Sep 2023, 17:29:33 UTC
Previous filing
04 Aug 2023
Next filing
08 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGN Common Stock Options Exercise $35,075 +11,500 +16% $3.05* 85,376 12 Sep 2023 Direct
transaction IMGN Common Stock Options Exercise $44,736 +9,832 +12% $4.55 95,208 12 Sep 2023 Direct
transaction IMGN Common Stock Options Exercise $19,997 +3,809 +4% $5.25 99,017 12 Sep 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGN Stock Option (right to buy) Options Exercise $0 -11,500 -100% $0.000000* 0 12 Sep 2023 Common Stock 11,500 $3.05 Direct F1
transaction IMGN Stock Option (right to buy) Options Exercise $0 -9,832 -60% $0.000000 6,555 12 Sep 2023 Common Stock 9,832 $4.55 Direct F2
transaction IMGN Stock Option (right to buy) Options Exercise $0 -3,809 -21% $0.000000 14,373 12 Sep 2023 Common Stock 3,809 $5.25 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on 7/18/2016 and is fully vested as of the transaction date.
F2 This option was granted on 2/7/2020 and is exercisable as to 25% on the first year anniversary of the grant and 6.25% quarterly for the subsequent three years.
F3 This option was granted on 1/31/2019 and is fully vested as of the transaction date.